NCT04241198View on ClinicalTrials.gov

Home Retinal Imaging Using NOTAL-OCT V3.0

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

July 30, 2022

Study Completion Date

March 28, 2023

Conditions
A. AMD Patients, Where at Least One Eye is With Active CNV, Presenting Retinal Fluid at the Enrolment Visit, Undergoing Active Anti-VEGF Treatment
Trial Locations (1)

Unknown

TLV Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Notal Vision Ltd.
All Listed Sponsors
lead

Notal Vision Ltd.

INDUSTRY

NCT04241198 - Home Retinal Imaging Using NOTAL-OCT V3.0 | Biotech Hunter | Biotech Hunter